ADAP Advocacy Urges HIV Medication Carve-Out in Medicare Drug Price Negotiations
ADAP Advocacy has called for an exemption for HIV antiretroviral therapies in Medicare's drug price negotiation program, highlighting the potential risks to people living with HIV/AIDS.
